Sciclone Pharma (SCLN) Reports Q1 EPS of $0.19

Sciclone Pharma (NASDAQ: SCLN) reported Q1 EPS of $0.19, versus $0.19 reported last year. Revenue for the quarter came in at $36.5 million, versus $33.6 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.

You May Also Be Interested In

• Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
• Veralto Corporation (VLTO) Tops Q1 EPS by 6c, Offers Guidance
• Texas Instruments (TXN) jumps on first above-consensus guide in seven years